P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
Xuan J. Wang(Vanderbilt University), Shaoying Li(The University of Texas MD Anderson Cancer Center), Carlos E. Bueso‐Ramos(The University of Texas MD Anderson Cancer Center), Yasuhiro Oki(The University of Texas MD Anderson Cancer Center), Guilin Tang(The University of Texas MD Anderson Cancer Center), Roberto N. Miranda, Zhenya Tang(The University of Texas MD Anderson Cancer Center), Nishitha Reddy(Vanderbilt University), Joseph D. Khoury(St. Jude Children's Research Hospital), L. Jeffrey Medeiros(The University of Texas MD Anderson Cancer Center), Sa Wang(The University of Texas MD Anderson Cancer Center), Parth Desai(The University of Texas MD Anderson Cancer Center)
Cited by 92
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Inhibition of JNK activation through NF-κB target genes
|Nature|2001|719